The pharmacologic effects of beta 2-adrenoceptor agonist drugs, including vilanterol, are at least in part attributable to stimulation of intracellular adenyl cyclase, the enzyme that catalyzes ...
Breo Ellipta, Tradjenta, Xifaxan, Vraylar, Janumet, and Otezla to be included in the second round of negotiations aimed at reducing drug costs for Medicare beneficiaries. On March 14, CMS said it ...
"As CMS continues to evolve its drug price negotiation programme ... ICER has published the research protocol (PDF) for the evaluation of Breo Ellipta and Trelegy Ellipta – which made £1.1 ...